LeonaBio (LONA) Current Leases (2020 - 2026)
LeonaBio (LONA) reported Current Leases of $478000.0 for Q1 2026, up 12.21% year-over-year from $426000.0 in Q1 2025, and up 2.8% on a QoQ basis from $465000.0 in Q4 2025.
LeonaBio (LONA) has 7 years of Current Leases data on file, last reported at $478000.0 in Q1 2026.
- Quarterly Current Leases rose 12.21% year-over-year to $478000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $478000.0 (up 12.21% YoY) and the FY2025 annual result came in at $465000.0, up 12.32% from the prior year.
- Current Leases improved to $478000.0 in Q1 2026 per LONA's latest filing, from $465000.0 in the prior quarter.
- Across five years, Current Leases topped out at $478000.0 in Q1 2026 and bottomed at $297000.0 in Q1 2022.
- The 5-year median for Current Leases is $380000.0 (2024), against an average of $382529.4.
- The widest annual swing landed in 2022, when Current Leases soared 48.5%; it then advanced 12.11% in 2025.
- Tracing LONA's Current Leases over 5 years: stood at $326000.0 in 2022, then advanced by 12.88% to $368000.0 in 2023, then advanced by 12.5% to $414000.0 in 2024, then increased by 12.32% to $465000.0 in 2025, then rose by 2.8% to $478000.0 in 2026.
- Per Business Quant, the three latest LONA Current Leases figures stand at $478000.0 (Q1 2026), $465000.0 (Q4 2025), and $452000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 478,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478,000.00 |
| Dec 31, 2025 | 465,000.00 |
| Sep 30, 2025 | 452,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 426,000.00 |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | 402,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 368,000.00 |
| Sep 30, 2023 | 358,000.00 |
| Jun 30, 2023 | 347,000.00 |
| Mar 31, 2023 | 337,000.00 |
| Dec 31, 2022 | 326,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 307,000.00 |
| Mar 31, 2022 | 297,000.00 |
| Dec 31, 2021 | 288,000.00 |
| Sep 30, 2021 | 279,000.00 |
| Jun 30, 2021 | 263,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 124,000.00 |
| Sep 30, 2020 | 57,000.00 |